JE 2147

Drug Profile

JE 2147

Alternative Names: AG 1776; KNI 764

Latest Information Update: 26 Sep 2003

Price : $50

At a glance

  • Originator Japan Energy Corporation
  • Class Antivirals; Dipeptides
  • Mechanism of Action HIV protease inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 26 Sep 2003 Discontinued - Phase-I for HIV infections treatment in USA (unspecified route)
  • 22 Jun 2000 Warner-Lambert has merged with Pfizer
  • 01 Dec 1999 Phase-I clinical trials for HIV infections treatment in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top